The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(4-(N-allyl-1H-indole-2-carboxamido)piperidin-1-yl)-4-oxobutanoic acid ID: ALA4088040
PubChem CID: 137643919
Max Phase: Preclinical
Molecular Formula: C21H25N3O4
Molecular Weight: 383.45
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: C=CCN(C(=O)c1cc2ccccc2[nH]1)C1CCN(C(=O)CCC(=O)O)CC1
Standard InChI: InChI=1S/C21H25N3O4/c1-2-11-24(21(28)18-14-15-5-3-4-6-17(15)22-18)16-9-12-23(13-10-16)19(25)7-8-20(26)27/h2-6,14,16,22H,1,7-13H2,(H,26,27)
Standard InChI Key: QWHVGOJZRRVGMX-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
11.9342 -6.9063 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.0573 -5.6805 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.0573 -6.4977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3524 -6.9063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6433 -6.4977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6433 -5.6805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3524 -5.2719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7664 -5.2719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7664 -4.4547 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.4740 -5.6808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2268 -6.4971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9335 -7.7235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6409 -8.1327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6402 -8.9499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5188 -6.9051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2275 -5.6799 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.7751 -6.5736 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.4352 -7.7191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6358 -7.8885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2297 -7.1802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4152 -7.1787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0057 -7.8847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4167 -8.5937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2299 -8.5918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1819 -5.2725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8894 -5.6814 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5973 -5.2731 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.8890 -6.4986 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
2 7 1 0
8 9 2 0
2 8 1 0
1 5 1 0
8 10 1 0
1 11 1 0
1 12 1 0
12 13 1 0
13 14 2 0
11 15 1 0
11 16 2 0
15 17 1 0
17 20 1 0
19 18 1 0
18 15 2 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
10 25 1 0
25 26 1 0
26 27 1 0
26 28 2 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 383.45Molecular Weight (Monoisotopic): 383.1845AlogP: 2.65#Rotatable Bonds: 7Polar Surface Area: 93.71Molecular Species: ACIDHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 4.29CX Basic pKa: ┄CX LogP: 1.10CX LogD: -1.87Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.72Np Likeness Score: -1.29
References 1. Jukič M, Ilaš J, Brvar M, Kikelj D, Cesar J, Anderluh M.. (2017) Linker-switch approach towards new ATP binding site inhibitors of DNA gyrase B., 125 [PMID:27689732 ] [10.1016/j.ejmech.2016.09.040 ]